From HealingMatters.Com, (http://www.healingmatters.com)
In the 1880's German scientists wondered what was the function of the Pancreas in anatomy. When they removed the Pancreas from a dog, they noted that its blood sugar rose uncontrollably. Thus the disease that produced high blood sugar came to be known as Diabetes and became identified with a nonfunctioning or improperly functioning Pancreas. Later when Insulin was identified as the causal agent in controlling blood sugar, a search was launched to isolate and synthesize Insulin.
In 1922, three Canadian nobel prize winners, Banting, Best and Macleod succeeded in saving the life of a fourteen year old diabetic girl in Toronto General Hospital with injectable Insulin. Eli Lilly was licensed to manufacture this new wonder drug and the medical community basked in the glory of a job well done. For a time Diabetes, as a disease, was controllable if not curable. No one liked the idea that the diabetic patient had to be supplied with Insulin all of his life, but the idea became accepted as better than premature death.
It wasn't until 1933 that rumors about this disease surfaced in a paper presented by Joslyn, Dublin and Marks and printed in the American Journal of Medicine. This paper "Studies on Diabetes Mellitus", discussed a major epidemic of a disease that looks very much like the Diabetes of the early 1920's only it does not respond to the wonder drug, Insulin. Even worse, sometimes Insulin treatment kills the patient. This disease became known as Insulin Resistant Diabetes because it had the symptoms of Diabetes, but did not respond well to Insulin therapy. Treatment of this disease by diet was started during this period.
Diabetes, which had a per capita incidence of 0.0028% at the turn of the century, had by 1933, zoomed 1000% to become a disease faced by many doctors. This disease was destined to go on to affect half of our population and to incapacitate almost 20% by the 1990's.
It wasn't until 1950 that the medical community was able to perform serum Insulin assays. This quickly revealed that the disease wasn't Diabetes, at least not in the accepted classical understanding of Diabetes. This new disease was characterized by sufficient, often excessive Insulin in the blood. The problem was that the Insulin didn't seem to work to reduce blood sugar; it was ineffective. But, since the disease had been known as Diabetes for almost twenty years it was renamed Type II diabetes to distinguish it from the earlier Type 1 diabetes characterized by insufficient insulin production by the pancreas.
In 1949, faced by what appeared to be an uncontrollable epidemic of the so called Insulin Resistant Diabetes, the medical community reorganized itself into the competing medical specialties that we see today. Thus the "Heart Specialist", "Endocrinologist", "Allergist", "Intestinal Disease Specialist", the "Cancer Specialist" and many others started. Of course, all of these symptoms of this new disease became diseases in their own right. Heart failure for example, which had been previously understood often to be but a symptom of Diabetes, now became a disease not directly connected to Diabetes. It became fashionable to think that diabetes "increased" Cardio-vascular risk. The causal role of a failed Blood Sugar Control System (BSCS) in Heart Failure became obscured.
A year later, in 1950, a search was launched for another "wonder drug" to deal with the Type II diabetes problem. The ideal drug would be, like Insulin, effective in remitting obvious adverse symptoms of the disease, but not effective in curing the underlying disease. It would be needed continually for the remaining life of the patient. It would have to be patentable; that is, it could not be a natural medication because these are non-patentable. Like Insulin, it would be economical to manufacture and distribute. Mandatory goverment approvals would be required to stimulate the use by physicians as a prescription drug. Testing required for these approvals would have to be enormously expensive to prevent other, unapproved medications from becoming competitive. If the drug had unexpected side effects, they could always be explained away by the fact that the disease was worse than the side effects. If the patient died, well, we did our best but this is after all a dangerous disease.
Consider; any drug that would really cure the disease would also put the drug manufacturer out of business in short order due to a lack of customers. Also any drug that was a natural agent, that could not be patented, was not only not a suitable drug company investment but had to be suppressed as unacceptable competition. The reason for this is the huge advertising budget for a natural, unpatented product could not be protected from other companies simply selling the product also without incurring any advertising costs. If the natural competing drug actually worked better than the synthetic drug, all the more reason to suppress it by force of law and to jail its proponents as quacks.
So it was important that the drug be patentable and not natural, effective enough to relieve symptoms, but not effective enough to cure the disease. The medical community also benefited from this approach, not only through the prescription monopoly that they enjoyed, but because the strategy produced the repeat business that they also needed in order to prosper economically.
Thus, was implemented the classic medical protocol of "treating the symptoms". By doing this, both the drug company and the doctor could stay in business and the patient, while not being cured, was often relieved of his symptoms. Enough money changed hands to make the American medical establishment the richest in the world. Unfortunately their patients have not been served as well.
It is important to note that prior to this time the medical goal was to cure disease because the patients usually would not accept anything less. After the introduction of Insulin sucessfully re-trained patients not to expect to be cured, the same commercial technique was applied to the new Hypoglycemic agents. Today all of the Hypoglycemic agents marketed to "control" Type II diabetes meet the original commercial criteria that we have listed above.
In 1955 the oral hypoglycemic drugs were introduced that have been with us for almost five decades. Some of these drugs, notably Rezulin, have been known to kill patients; yet, they remain on the market for unexplainable lengths of time with regulatory agency approval.
Today almost half of the people in the country suffer from one or more symptoms of this disease and it has become well known to physicians asType II diabetes, "Insulin Resistant Diabetes, Insulin Resistance, or more rarely Hyperinsulinemia. One wonders why this "stealth disease" has so many aliases.
When research scientists tried to make sense out of these disease aliases they found conventional medical terminology too confusing to allow useful communication among themselves about the disease. How can you discuss a disease that had as many aliases as there are medical specialties? How does one discuss a disease with their peers that has literally dozens, if not hundreds, of major symptoms and no apparent causative mechanism? This alias, or AKA, type communication problem was resolved when the scientific community by abandoned all of the convential medical aliases and identified the disease simply as Syndrome X. It is called a syndrome because it has such a huge number of symptoms. The symptom set includes all of the listed diseases on our home page and many more as well. The basic underlying disorder, Syndrome X, is a derangement of the Blood Sugar Control System by poisonous fats and oils. It is exacerbated and complicated by the near universal lack of other essential nutrition that the body needs to cope with the metabolic consequences of these poisons.
Elevated Cholesterol levels, high Triglyceride levels, Hypertension (High Blood Pressure), inability to metabolize fats and oils, all of the symptoms listed on this home page as well as the well known inability to metabolize Carbohydrates are all symptomatic of this disease. According to the American Heart Association, over 50% of Americans suffer from one or more of these symptoms. We discuss this from a different perspective on our Hyperinsulinemia page.
When I discovered that this disease appeared quite suddenly in the early 1930's, I wanted to know what else had happened then that might be studied as a causal agent for the disease. It turns out there is a causal agent that originated during the 1920's and which modern biochemists have now connected to the extraordinary disease epidemic in which we are involved. This causal agent is the systematic commercialization and corruption of our food supply starting with our fats and oils.
As early as 1901, efforts had been made to manufacture and sell food products by the use of automated factory machinery because of the immense potential profits that were possible. Most of the early efforts failed because people were inherently suspicious of food that wasn't farm fresh and because the technology was poor. Safeway, for example, was reputed to have chosen its name as an assurance to its customers that it would not sell adulterated food. As long as people were prosperous, "suspicious food products" made little headway. Crisco, the artificial shortening, was given away free in 2 1/2 lb cans in an unsucessful effort to influence the wives of the nation to trust and buy the product in preference to lard.
Margarine was introduced and bitterly opposed by the dairy states. With the advent of the depression, Margarine, Crisco and a host of other Refined and Hydrogenated products began to make significant penetration into the food markets of the nation. Support for dairy opposition to Margarine faded during WW II because there wasn't enough butter for the civilian population and the needs of the military. At this point, the dairy industry having lost much support, simply accepted a diluted market share and concentrated on supplying the military. Flax oils and fish oils, which were common in the stores and considered a dietary staple before our nation became diseased, disappeared from the shelf; the last supplier of flax oil to the major distribution chains was Archer Dainiels Midland and they discontinued the product in 1950.
The history of the adulteration of our once clean food supply exactly parallels the rise of the epidemic Hyperinsulinemia that now lies at the root of many, if not most, of the degenerative diseases from which we suffer.
On our Hyperinsulinemia page we discuss much more about the nature of this disease, including effective ways to reverse its progress. More information is available in our Special Report in hardcopy form about the relationship of artificial fats and oils to this disease. Our Special Report also provides additional detail on the food factors that we must guard against and the best way to recognise the food products that cause this disease.
Mirrored from HealingMatters.Com at http://www.healingmatters.com